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Abstract
Intestinal inflammation changes the luminal habitat for microbes through mechanisms that have not been fully resolved.
We noticed that the FepE regulator of very long O-antigen chain assembly in the enteric pathogen Salmonella enterica
serotype Typhimurium (S. Typhimurium) conferred a luminal fitness advantage in the mouse colitis model. However, a fepE
mutant was not defective for survival in tissue, resistance to complement or resistance to polymyxin B. We performed
metabolite profiling to identify changes in the luminal habitat that accompany S. Typhimurium-induced colitis. This analysis
suggested that S. Typhimurium-induced colitis increased the luminal concentrations of total bile acids. A mutation in fepE
significantly reduced the minimal inhibitory concentration (MIC) of S. Typhimurium for bile acids in vitro. Oral administration
of the bile acid sequestrant cholestyramine resin lowered the concentrations of total bile acids in colon contents during S.
Typhimurium infection and significantly reduced the luminal fitness advantage conferred by the fepE gene in the mouse
colitis model. Collectively, these data suggested that very long O-antigen chains function in bile acid resistance of S.
Typhimurium, a property conferring a fitness advantage during luminal growth in the inflamed intestine.
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Introduction
Salmonella enterica serotype Typhimurium (S. Typhimurium) is an
important cause of human gastroenteritis [1]. Upon ingestion, a
fraction of the S. Typhimurium population enters intestinal
epithelial cells using the invasion-associated type III secretion
system (T3SS-1) [2], which is followed by macrophage survival
mediated by a second type III secretion system (T3SS-2) [3]. The
deployment of T3SS-1 and T3SS-2 triggers acute intestinal
inflammation [4] and the resulting changes in the environment
enhance growth of the luminal fraction of the S. Typhimurium
population [5,6,7,8] despite the fact that concentrations of
antimicrobial substances are elevated in this habitat [9,10,11].
The surface of S. Typhimurium, which is exposed to
antimicrobial substances in the inflamed gut, is decorated with
lipopolysaccharide (LPS). The oligosaccharide core connects the
lipid A moiety, which anchors the LPS molecule in the outer
membrane, to O-antigen repeat units that extend from the
bacterial surface. Each O-antigen repeat unit is composed of a
trisaccharide backbone, consisting of a-D-mannose-(1,4)-a-L-
rhamnose-(1,3)-a-D-galactose, and a branching sugar (abequose)
that is a-(1,3)-linked to D-mannose in the backbone. S.
Typhimurium can produce short LPS species containing between
1 and 15 O-antigen repeat units. Additionally, S. Typhimurium
synthesizes LPS species containing a greater number of O antigen
repeat units, which requires the length regulators WzzB [12,13]
and FepE [14]. The WzzB protein regulates the assembly of long
LPS species carrying between 16 and 35 O-antigen repeat units
[15] while the FepE protein controls the biosynthesis of very long
LPS species with more than 100 O-antigen repeat units [14].
These regulatory mechanisms give rise to a tri-modal distribution
in LPS length.
There is general agreement that WzzB-dependent assembly of
long O-antigen chains (16–35 repeat units) provides a fitness
advantage by conferring resistance to complement [14,16]. In
contrast, the function of very long O-antigen chains (.100 repeat
units) during host microbe interaction remains unclear. The
absence of very long O-antigen species in a fepE mutant reduces in
vitro translocation of SipA [16], a T3SS-1 effector protein that
significantly contributes to the induction of inflammation in the
mouse colitis model [17]. However, in vivo the O-antigen is not
required for T3SS-1-dependent induction of intestinal inflamma-
tory responses [18]. These data indicate that SipA translocation
proceeds through an O-antigen-independent pathway in vivo. One
study suggests that very long O-antigen inhibits macrophage
phagocytosis [19], while others observed no inhibition [16]. A fepE
mutant and its S. Typhimurium wild-type parent are equally
resistant to complement in vitro, although a wzzB fepE mutant is
more serum sensitive than a wzzB mutant [14,16,20]. Importantly,
an S. Typhimurium fepE mutant retains full virulence in the mouse
typhoid model [14], suggesting that complement resistance and
resistance to phagocyte-mediated killing mechanisms are inde-
pendent of very long O-antigen chains in vivo. Since no phenotype
has been described for a S. Typhimurium fepE mutant in mouse
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models, it remains unclear which selective forces prevent loss of
very long O-antigen chains.
In the absence of selective forces to maintain the costly
production of very long O-antigen chains, the fepE gene is
predicted to accumulate point mutations and eventually become
inactive. Interestingly, fepE is a pseudogene in S. enterica serotype
Typhi, the causative agent of typhoid fever [21]. We thus reasoned
that fepE might be involved in aspects of host pathogen interaction
that are important during gastroenteritis (caused by S. Typhimur-
ium) but dispensable during typhoid fever (caused by S. Typhi).
While S. Typhimurium transmission requires maximum growth in
the lumen of the inflamed intestine [22], S. Typhi persists in the
human population through chronic gall bladder carriage [23,24].
Based on these considerations, we proposed that very long O-
antigen chains might enhance the fitness of S. Typhimurium in the
environment of the inflamed intestine during gastroenteritis. We
tested this hypothesis using the mouse colitis model and elucidated
the underlying mechanism.
Results
Very long O-antigen chains confer a luminal growth
advantage in the inflamed gut
To study the role of very long O-antigen chains, we generated a
fepE mutant of the S. Typhimurium wild type strain IR715. The
fepE mutant (RC31) was deficient for producing very long O-
antigen chains, and this defect could be restored by introducing
the cloned fepE gene (pCR37) on a plasmid (Fig. S1A). Consistent
with previous reports [14,16], the S. Typhimurium wild type
(IR715) and the fepE mutant (RC31) exhibited similar levels of
serum resistance (Fig. S1B). In contrast, a wzzB mutant that lacked
long O-antigen chains but retained the ability to produce very long
O-antigen chains (Fig. S1A) exhibited significantly (P,0.01)
reduced serum resistance (Fig. S1B).
Genetically resistant mice infected with S. Typhimurium exhibit
little intestinal inflammation during the first three days after
inoculation (mouse typhoid model) [25]. In contrast, mice treated
with streptomycin develop severe acute cecal inflammation within
2 days after infection (mouse colitis model). To determine whether
very long O-antigen chains confer a fitness advantage during
conditions of acute intestinal inflammation, we performed a pilot
experiment in which streptomycin pre-treated, genetically suscep-
tible mice (C57BL/6J) were infected intragastrically with an equal
mixture of the S. Typhimurium wild type (IR715) and a fepE
mutant (RC31) (mouse colitis model). By day four after infection,
mice became moribund and the wild type was recovered in higher
numbers than the fepE mutant from intestinal contents, but not
from liver and spleen (Fig. S2).
To determine whether the luminal fitness advantage conferred
by the fepE gene would increase over time, groups of streptomycin
pre-treated, genetically resistant mice (129/SvJ) were infected
intragastrically with an equal mixture of the S. Typhimurium wild
type (IR715) and a fepE mutant (RC31) (mouse colitis model). For
comparison, mice (129/SvJ) that had not been pre-treated with
streptomycin were infected with the same mixture of S.
Typhimurium strains (mouse typhoid model). In the mouse
typhoid model, the wild type did not exhibit a luminal growth
advantage over the fepE mutant as indicated by recovery of
bacteria from feces (Fig. 1A) or colon contents (Fig. 1B). In
contrast, the wild type was recovered in significantly higher
numbers (P,0.05) from feces starting at day 3 after infection in the
mouse colitis model (Fig. 1A). By day 7 after infection, the wild
type was recovered in greater than 100-fold excess over the fepE
mutant (Fig. 1B). In both the mouse typhoid model and in the
mouse colitis model, the S. Typhimurium wild type and fepE
mutant were recovered in similar numbers from the liver and
spleen (Fig. 1C), suggesting that very long O-antigen chains are
dispensable for growth in tissue. As expected, histopathogical
analysis revealed a greater severity of cecal inflammation in the
mouse colitis model compared to the mouse typhoid model seven
days after infection (Fig. 1 and E). Bacteria recovered from
intestinal contents of streptomycin pretreated mice exhibited
strong expression of very long O-antigen chains, as indicated by
Western blot analysis (Fig. S3).
Production of very long O-antigen chains had a similar effect on
bacterial numbers in the mouse colitis model when we used CBA/
J mice, a lineage that is also genetically resistant to S.
Typhimurium infection (Fig. S4A and S4B). To assess comple-
mentation in vivo, streptomycin pre-treated CBA/J mice were
infected with an equal mixture of a S. Typhimurium fepE mutant
(RC61) and a derivative carrying the fepE gene inserted upstream
of the phoN gene (phoN::fepE) (RC62). The complemented strain
(RC62) was recovered in higher numbers from feces and colon
contents (Fig. S4C), suggesting that an intact chromosomal copy of
the fepE gene could restore the fitness defect of a fepE mutant.
Next, we investigated whether the fitness advantage conferred by
very long O-antigen chains was apparent in mice infected with
individual S. Typhimurium strains (single infection design).
Streptomycin pre-treated CBA/J mice were infected with either
the S. Typhimurium wild type (IR715) or a fepE mutant (RC31)
(mouse colitis model). Mice infected with the S. Typhimurium wild
type shed significantly (P,0.01) higher bacterial numbers with
their feces than mice infected with the fepE mutant (Fig. S4E),
while similar bacterial loads were recovered from liver and spleen
(Fig. S4D).
T3SS-1 and T3SS-2 cooperate to induce intestinal inflamma-
tion in the mouse colitis model [26,27]. Inactivation of both T3SS-
1 (through a mutation in invA) and T3SS-2 (through a mutation in
spiB) renders the resulting S. Typhimurium double mutant strain
unable to trigger intestinal inflammation [9]. To further investi-
gate why very long O-antigen chains conferred a fitness advantage
in the mouse colitis model, streptomycin pre-treated mice (129/
SvJ) were infected with an equal mixture of an invA spiB mutant
(SPN452) and an invA spiB fepE mutant (RC55). Mice infected with
this mixture did not developed intestinal inflammation (Fig. 1A
and 1B) and the invA spiB mutant did not exhibit a luminal growth
advantage over the invA spiB fepE mutant (Fig. 1A and 1B). Due to
the attenuation caused by mutations in invA and spiB, neither strain
Author Summary
Microbial communities inhabiting the intestinal tract have
been characterized using high-throughput sequencing
approaches, but little is known about factors that change
their luminal habitat. Using metabolite profiling we
discovered that luminal concentrations of total bile acids
become significantly elevated during Salmonella-induced
colitis. Very long O-antigen chains of Salmonella enterica
serotype Typhimurium (S. Typhimurium) were required for
luminal growth in the presence of such elevated bile
concentrations during colitis. In contrast, very long O-
antigen chains were dispensable for luminal growth in the
presence of normal concentrations of bile acids or for
growth in organs of mice. Thus, elevated bile concentra-
tions during Salmonella-induced colitis change the luminal
habitat and microbial growth in this environment requires
increased bile resistance, which in case of S. Typhimurium
is conferred by very long O-antigen chains.
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was recovered from the liver and spleen of mice seven days after
infection (Fig. 1C). Collectively, these data pointed to the lumen of
the acutely inflamed intestine as the habitat conferring a fitness
advantage to S. Typhimurium expressing very long O-antigen
chains. However, the mechanism by which very long O-antigen
chains would provide a benefit in the environment of the inflamed
gut remained unclear.
Metabolite profiling of luminal changes during S.
Typhimurium induced colitis
To identify potential small molecule candidates that might
explain the fitness advantage conferred by very long O-antigen
chains in the inflamed gut, groups of streptomycin pre-treated
mice (n = 4) were inoculated with sterile LB broth (mock infection)
or S. Typhimurium. Four days after infection, the ceca were
collected and metabolites extracted from the mucosa with water.
Metabolites in these cecal washes were analyzed after removing
bacteria by filtration to avoid contamination of samples with
bacterial intracellular metabolites. Samples underwent hydrophilic
interaction chromatography - liquid chromatography/mass spec-
trometry (HILIC-LC/MS) metabolic profiling. Peak metabolite
values were measured for cecal washes of each animal and data
were transformed logarithmically (log2) for statistical analysis and
determination of false discovery rates. More than 800 components
were detected by HILIC-LC/MS. Principle component analysis
revealed group clustering of samples from mock-infected mice and
S. Typhimurium-infected mice (Fig. S5), suggesting that S.
Typhimurium infection was accompanied by characteristic
changes in the luminal environment.
We were able to assign metabolite identities to 67 components
(Table S1). A total of 20 components met the criteria for at least a
2-fold change between samples from mock-infected and S.
Figure 1. Very long O-antigen chains confer a fitness advantage in the lumen of the inflamed gut. Mice (129/SvJ) were treated with
streptomycin or were left untreated and were subsequently infected with equal mixtures of the indicated S. Typhimurium strains. (A) Competitive
indices (CI) recovered from feces over time. (B) Competitive indices recovered from colon contents. (C) Competitive indices recovered from the liver
and spleen. (A–C) Bars represent geometric means 6 standard error. *, P,0.05; **, P,0.01, NR, no bacteria recovered. (D) Combined histopathology
score of pathological changes observed in sections from the cecum. Lines represent averages. Each circle or diamond represents the combined
histopathology score from an individual animal. (E) Representative images of histopathological changes.
doi:10.1371/journal.ppat.1002918.g001
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Typhimurium-infected mice and a P value of less than 0.1, which
is illustrated in a volcano plot in Figure 2A. Of these, 15
components were considered significantly changed (P,0.05;
q,0.1) between both groups. We were able to assign metabolite
identities to four of the six components that were significantly
(P,0.05; q,0.1) increased in samples from S. Typhimurium-
infected mice compared to mock-infected animals (Fig. 2B).
Interestingly, one of these metabolites, phosphatidylinositol 3-
phosphate, is produced in host cells by the T3SS-1 effector protein
SopB [28]. Two metabolites were breakdown products of
phosphatidylethanolamine (lysophosphatidylethanolamine [14:1])
and phosphatidylcholine (lysophosphatidylcholine [16:1]), respec-
tively. The fourth metabolite with significantly increased abun-
dance (P,0.05; q,0.1) in samples from S. Typhimurium infected
mice was the bile acid tauromurocholate. These data indicated
that increased levels of bile acids might accompany S. Typhimur-
ium infection, thereby identifying a potential candidate for an anti-
microbial metabolite that is elevated during colitis.
To validate results from metabolite profiling, the concentration
of total bile acids was determined in colon contents recovered from
the mouse typhoid model and from the mouse colitis model using
an enzymatic assay. The concentration of total bile acids was
significantly (P,0.01) increased in the mouse colitis model,
compared to the mouse typhoid model or to mock-infected mice
(Fig. 2C). These data suggested that the concentration of total bile
acids was increased during S. Typhimurium-induced colitis.
Furthermore, these data established an inverse correlation
between luminal concentrations of total bile acids (Fig. 2C) and
the luminal fitness of the fepEmutant (Fig. 1A and 1B) but fell short
of establishing cause and effect.
Very long O-antigen chains increasing resistance to bile
To investigate whether an increased concentration of total bile
acids during S. Typhimurium-induced colitis was the mechanism
responsible for the fitness advantage conferred by very long O-
antigen chains (Fig. 1), we first determined the minimal inhibitory
concentration (MIC) of S. Typhimurium strains to ox bile extract
(sodium choleate) in vitro (Table 1). The MIC of sodium choleate
was identical for the S. Typhimurium wild type (IR715) and a
wzzB mutant (RC46). However, compared to the wild type, the
MIC of sodium choleate for the fepE mutant (RC31) was reduced.
Introduction of the cloned fepE gene (pCR37) into the fepE mutant
restored resistance to sodium choleate. Lack of very long O-
antigen chains in the fepE mutant did not reduce the MIC for the
anionic detergent sodium dodecyl sulfate (SDS) or for the cationic
antimicrobial peptide polymyxin B. In contrast, a mutation in
pmrE, a gene necessary for 4-aminoarabinose lipid A modification
[29], increased sensitivity to the antimicrobial peptide polymyxin
B, but not to the anionic detergent SDS. Collectively, these data
suggested that very long O-antigen chains, but not long O-antigen
chains, are specifically required for full resistance to bile acids.
Since the MIC of the fepE mutant for sodium choleate (2%) was
nearly 100-fold higher than the concentration of bile acids
measured in intestinal contents (Fig. 2C), we compared growth
of the S. Typhimurium wild type and a fepE mutant in medium
containing different concentrations of bile acids. As expected,
medium containing 3% sodium choleate supported growth of the
S. Typhimurium wild type (MIC 12%) but fully suppressed growth
of the fepE mutant (MIC 2%) (Fig. S6A). Growth of the fepE
mutant was retarded compared to that of the S. Typhimurium
wild type in medium containing 0.3% sodium choleate (Fig. S6B)
or 0.03% sodium choleate (Fig. S6C). Finally, both strains grew
equally in medium containing 0.003% sodium choleate (Fig. S6D).
These data suggested that very long O-antigen chains conferred a
fitness advantage at concentrations of bile acids that were
approximately two orders of magnitude below the MIC of the
fepE mutant (Table 1).
The concentration of total bile acids in intestinal contents can
be lowered by bile sequestrants, such as cholestyramine resin, a
compound used clinically to restrict cholesterol and fat intake. To
investigate whether bile sequestrants could rescue growth of the
fepE mutant in medium containing sodium choleate, MIC values
Figure 2. Bile acids are elevated during S. Typhimurium-
induced colitis. (A) Groups of streptomycin pre-treated mice were
inoculated with sterile LB broth (mock infection, n = 4) or with S.
Typhimurium (n = 4). Four days after infection, water extracts of
metabolites from the cecal mucosa were analyzed by HILIC-LC/MS
metabolite profiling. For each component detected by HILIC-LC/MS,
peak areas from four mock-infected animals were averaged and
compared to the average peak areas from four S. Typhimurium-
infected animals. Each dot in the volcano plot represents the fold-
change between mock-infected and S. Typhimurium-infected mice for
one component. Components with at least a 2-fold change and a P
value of less than 0.1 are indicated in pink. (B) List of metabolites
showing at least a 2-fold increase during S. Typhimurium infection.
Letters correspond to letters in panel A. Lys-PE, lysophosphatidyletha-
nolamine; Lys-PC, lysophosphatidylcholine. (C) Determination of
concentrations of total bile acids in colon contents. Bars represent
geometric means 6 standard error. **, P,0.01.
doi:10.1371/journal.ppat.1002918.g002
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were determined in vitro in the presence of cholestyramine resin
(Table 1). The S. Typhimurium wild type and the fepE mutant
exhibited identical MIC values for sodium choleate in the presence
of cholestyramine resin.
To test whether increased concentrations of total bile acids are
responsible for the fitness advantage conferred by very long O-
antigen chains in the mouse colitis model, animals fed rodent chow
containing cholestyramine resin or control chow were pretreated
with streptomycin and inoculated with sterile LB broth (mock
infection) or with an equal mixture of the S. Typhimurium wild
type (IR715) and a fepE mutant (RC31). While the S. Typhimur-
ium wild type was recovered in significantly higher numbers from
feces (Fig. 3A) and colon contents (Fig. 3B) of mice fed control
chow, this competitive advantage was abrogated in mice fed chow
containing cholestyramine resin. Concomitantly, diet containing
cholestyramine resin significantly (P,0.05) reduced the concen-
tration of total bile acids in colon contents present during S.
Typhimurium infection (Fig. 3C) but did not reduce the severity of
intestinal inflammation (Fig. 3D and 3E). These data provided
direct support for the idea that increased concentrations of total
bile acids during S. Typhimurium-induced colitis reduced the
fitness of bacteria lacking very long O-antigen chains.
Discussion
S. Typhimurium-induced colitis is accompanied by elevated
luminal concentrations of several antimicrobial proteins, including
lipocalin-2 [9], calprotectin [11], regenerating islet-derived 3
gamma (RegIIIc) [30] and RegIIIb [10]. In some cases, specific
resistance mechanisms against these antimicrobial proteins have
been shown to confer a fitness advantage in the lumen of the
inflamed gut. For example, the ability to synthesize the side-
rophore salmochelin confers resistance to lipocalin-2 [31], a
property that boosts luminal growth of S. Typhimurium in the
mouse colitis model [9]. Similarly, the high affinity zinc
transporter ZnuABC confers resistance to the zinc-binding protein
calprotectin, thereby enhancing luminal growth of S. Typhimur-
ium during colitis [11].
Here we used metabolite profiling to determine whether small
antimicrobial metabolites are elevated during S. Typhimurium-
induced colitis. Our results identify bile acids as a class of small
antimicrobial molecules whose concentration is elevated in the
mouse colitis model. A previous metabolite profiling study
detected elevated bile acid biosynthesis in the mouse typhoid
model by analyzing acetonitrile extracts from feces [32]. Total
concentrations of bile acids in feces and fecal water are elevated
two to five times in patients with inflammatory bowel disease
[33]. However, fecal concentrations of total bile acids are
significantly decreased during dextran sulfate sodium (DSS)-
induced colitis in rats [34]. Thus, an increased concentration of
bile acids is not likely to be a general feature of intestinal
inflammation, but might involve mechanisms that are only
triggered in a subset of inflammatory disorders, including S.
Typhimurium-induced colitis. It should be noted that due to
absorption in the large intestine, bile concentrations might be
higher in the ileum, the primary site of S. Typhimurium infection
in humans. The mouse is not an ideal model to study luminal
growth in the ileum, because the bulk of luminal S. Typhimurium
are present in the cecum.
The absence of acute colitis during typhoid fever might
explain why fepE is a pseudogene in S. Typhi [21]. However, S.
Typhi requires bile resistance for persistence in the gall bladder.
It is possible that other long surface carbohydrates, such as the
Vi-capsular polysaccharide or the O-antigen capsule [35,36],
can compensate for the lack of very long O-antigen chains
during growth in the environment of the gall bladder.
Nonetheless, our data show that very long O-antigen chains
increased the fitness of S. Typhimurium in the lumen of the
acutely inflamed intestine by mediating bile resistance, which
represents the first function ascribed to this surface structure.
Inactivation of yrbK and rlpB, two genes implicated in LPS
transport, increases bile resistance of S. Typhimurium and
correlates with differences in the oligosaccharide units that form
long-chain LPS [37]. However, our data suggest that long O-
antigen chains do not confer resistance to bile. Conversely, long
O-antigen chains confer serum resistance, while very long O-
antigen chains are dispensable for this trait [14,16]. Thus, long
O-antigen chains and very long O-antigen chains do not have
redundant functions.
The picture emerging from these studies is that very long O-
antigen is important for growth of S. Typhimurium in the lumen
of the inflamed intestine. Maximum growth in the intestinal lumen
is of relevance, because it enhances transmission by the fecal-oral
route [22], which is predicted to confer a selective advantage. We
conclude that the role of very long O-antigen chains in bile
resistance likely represents one of the selective forces that help to
maintain the fepE gene in the genomes of non-typhoidal Salmonella
serotypes.
Materials and Methods
Bacterial strains, plasmids, and growth conditions
Bacterial strains and plasmids used in this study are presented in
Table 2. Cultures of S. Typhimurium and Escherichia coli were
routinely incubated with aeration at 37uC in Luria-Bertani (LB)
broth (10 g tryptone, 5 g yeast extract, and 10 g NaCl per liter) or
on LB agar plates unless indicated otherwise. Antibiotics were
added as necessary at appropriate concentrations: chloramphen-
icol (Cm), 0.03 mg/ml; carbenicillin (Cb), 0.1 mg/ml; kanamycin
(Kan), 0.05 mg/ml; and nalidixic acid (Nal), 0.05 mg/ml.
Table 1. Very long O-antigen chains confer resistance to bile acids.
Genotype
MIC for
Polymyxin B MIC for SDS
MIC for sodium
choleate
MIC for sodium choleate in the presence
of 100 mg/ml cholestyramine resin
Wild-type 1.2 mg/ml 12% 12% 20%
fepE 1.2 mg/ml 12% 2% 20%
fepE (pCR37) 1.2 mg/ml 12% 12% 20%
wzzB 1.2 mg/ml 12% 12% 20%
pmrE 0.5 mg/ml 12% 12% 20%
doi:10.1371/journal.ppat.1002918.t001
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Construction of mutants and plasmids
Nucleotide sequences of oligonucleotide primers used for
cloning are listed in Table 3. Internal fragment of S. Typhimurium
the fepE and wzzB genes were polymerase chain reaction (PCR)
amplified using primer pairs 62/63 and 150/151, respectively, and
cloned into pCR2.1 (Invitrogen) to give rise to plasmids pRC30
and pRC48. The inserts were excised using restriction endonu-
clease digestion with SmaI and SalI (pRC30) or SacII and XhoI
(pRC48) and cloned into suicide vector pGP704 digested with
SmaI and SalI or into suicide vector pEP185.2 digested with SacII
and XhoI to yield plasmids pRC31 and pRC49, respectively.
Plasmids pRC31 and pRC49 were introduced into S. Typhimur-
ium IR715 by conjugation with E. coli S17-1 lpir and exconjugants
were designated RC31 and RC46, respectively. The wild-type fepE
gene was PCR amplified using the primer pair 52/53 and cloned
into pCR2.1 to yield plasmid pRC36. The insert of pCR36 was
excised with EcoRI and cloned into low copy vector pWSK129 to
yield pRC37. To construct a pmrE mutant, an internal fragment of
the S. Typhimurium pmrE gene was PCR amplified using primers
263/264, cloned into pCR2.1 to yield plasmid pSW197. The
insert of pSW197 was cloned into suicide plasmid pFUSE at XbaI
and SmaI restriction sites to yield plasmid pSW198. Plasmid
Figure 3. The bile sequestrant cholestyramine resin reduces the fitness advantage conferred by very long O-antigen chains in the
mouse colitis model. Mice (129/SvJ) receiving chow containing cholestyramine resin or control chow were pre-treated with streptomycin and
infected with an equal mixture of the S. Typhimurium wild type and a fepE mutant. (A) Competitive indices recovered from feces over time. (B)
Competitive indices recovered from colon contents. (C) Determination of concentrations of total bile acids in colon contents. (A–C) Bars represent
geometric means 6 standard error. *, P,0.05; **, P,0.01. (D) Combined histopathology score of pathological changes observed in sections from the
cecum. Lines represent averages. Each circle or diamond represents the combined histopathology score from an individual animal. (E) Representative
images of histopathological changes.
doi:10.1371/journal.ppat.1002918.g003
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pSW198 was introduced into S. Typhimurium IR715 by
conjugation to yield strain SW698. The fepE::pGP704 mutation
was transduced from RC31 into the S. Typhimurium invA spiB
mutant SPN452 using transduction with phage P22 HT int-105 to
yield strain RC55.
To construct a fepE deletion mutant, primers 170 and 171 were
used to PCR amplify the region upstream of S. Typhimurium fepE
(flanking region 1) from base 3537 of entF to base 248 of fepE.
Primers 172 and 173 were used to PCR amplify the downstream
region of S. Typhimurium fepE (flanking region 2) from base 1136
of fepE to base 322 of fepC. PCR products for the fepE upstream
and downstream regions were gel purified (Qiagen), digested with
XbaI, and ligated together with T4 DNA ligase (NEB). The
ligation reaction served as a template for PCR amplification of the
fepE flanking region construct using primers 170 and 173, and this
product was gel purified and cloned into pCR2.1 (Invitrogen) to
generate pRC50. The cassette containing fepE flanking regions was
excised from pRC50 using SalI, ligated into SalI-digested
pRDH10 using the Quick T4 DNA Ligase kit (NEB) to generate
pRC51. The KSAC cassette from pBS34 was excised by XbaI
digestion and ligated into the XbaI site of pRC51 to yield pRC52.
Plasmid pRC52 was conjugated into S. Typhimurium IR715. An
exconjugant selected on plates containing LB+Nal+Km was
designated RC61 and deletion of fepE was confirmed by PCR.
For complementation, the S. Typhimurium wild type fepE allele
was PCR amplified using primers 174 and 175 from base 2350 of
fepE to base 1136 of fepE, and cloned into pCR2.1 to give rise to
plasmid pRC53. The insert was excised using restriction
endonuclease digestion with SalI and SmaI and ligated into SalI-
and SmaI-digested pSW84, a suicide plasmid carrying a DNA
fragment upstream of the phoN open reading frame, to yield
pRC54. Plasmid pRC54 was introduced into RC61 by conjuga-
tion with E. coli S17-1 lpir and an exconjugant carrying pRC54
integrated into the phoN locus was designated RC62.
Analysis of LPS
Bacterial cultures grown 16 hours at 37uC in LB broth were
suspended in 1 ml Dulbecco’s phosphate buffered saline (DPBS,
Gibco) at a concentration of approximately 16109 CFU/ml.
Samples were washed three times in DPBS (12,0006 g for
4 minutes). The pellet was resuspended in 0.1 ml lysis buffer
(0.5 M Tris-HCl at pH 6.8, 4% sodium dodecyl sulfate [SDS],
40% glycerol, 0.2% bromophenol blue, and 10% b-mercaptoeth-
anol) and boiled for 10 minutes. We then added 0.1 ml of
proteinase K solution (Invitrogen) (20 mg proteinase K/ml in
10 mM Tris-HCl, 50% glycerol, and 20 mM CaCl2) and
incubated for 3 hours at 65uC. LPS preparations were boiled
again for 10 minutes, and 0.02 ml of each sample loaded on a
15% SDS-polyacrylamide gel electrophoresis (SDS-PAGE), and
visualized by silver staining as described previously [38].
Table 2. Bacterial strains and plasmids used in this study.
Designation Genotype Source or Reference
E. coli strains
Top10 F- mcrA D(mrr-hsdRMS-mcrBC) Q80lacZDM15 lacX74 recA1
araD139 D(ara, leu)7697 galU galK rpsL endA1 nupG
Invitrogen
S17-1 lpir F- recA thi pro rK- mK+ RP4:2-Tc::MuKm Tn7 lpir [40]
S. Typhimurium strains
IR715 ATCC 14028, NalR [41]
RC31 IR715, fepE::pGP704 (CarbR) This study
RC46 IR715, wzzB::pEP185.2 (CmR) This study
SPN452 IR715, invA(29 to +2057)::tetRA spiB(+25 to +1209)::KSAC [9]
RC55 IR715, invA(29 to +2057)::tetRA spiB(+25 to +1209)::KSAC fepE::pGP704 This study
SW698 IR715, pmrE::pFUSE This study
Plasmids
pCR2.1 Cloning Vector (CarbR, KmR) Invitrogen
pGP704 Suicide plasmid, oriR6K mobRP4 (CarbR) [42]
pEP185.2 Suicide plasmid, oriR6K mobRP4 (CmR) [43]
pFUSE Suicide plasmid, oriR6K mobRP4 ‘lacZYA (CmR) [44]
pWSK129 pSC101 ori (KmR) [45]
pRC30 pCR2.1::‘fepE’ This study
pRC31 pGP704::‘fepE’ This study
pRC36 pCR2.1::fepE This study
pRC37 pWSK129::fepE This study
pRC48 pCR2.1::‘wzzB’ This study
pRC49 pEP185.2::‘wzzB’ This study
pRC54 pSW84::fepE This study
pSW84 pGP704::phoN’ [46]
pSW197 pCR2.1::‘pmrE’ This study
pSW198 pFUSE::‘pmrE’ This study
doi:10.1371/journal.ppat.1002918.t002
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LPS purified from colon and cecal contents was probed with
anti-Salmonella O:4 serum (Becton, Dickinson and Company) for
production of the somatic O antigen by Western blot analysis.
CFU of S. Typhimurium were determined for each sample and
samples loaded in each lane were normalized to represent
equivalent amounts of bacteria. Preparations were separated by
15% SDS-PAGE, transferred to an Immobilon PVDF membrane
(Millipore) using a Trans-Blot semidry transfer apparatus (Bio-
Rad), and detected with anti-Salmonella O:4 serum and an alkaline
phosphatase-conjugated goat anti-rabbit secondary antibody (Bio-
Rad Laboratories). Bands were visualized following exposure and
development on a BioSpectrum AC Imaging System (Ultra-Violet
Products).
Determination of MIC values
To determine MIC values of S. Typhimurium strains against
polymyxin B (Sigma Aldrich), SDS (USB Corporation), sodium
choleate (a crude ox bile extract from Sigma Aldrich, which
contains the sodium salts of taurocholic, glycocholic, deoxycholic,
and cholic acids), or with a combination of sodium choleate and
cholestyramine resin (DOW Chemical Company), overnight
cultures were washed twice in DPBS, diluted to 16103 cells per
ml with antimicrobial compounds in sterile LB broth (polymyxin
B: 0–1.5 mg/ml, increments of 0.1 mg/ml; SDS and sodium
choleate: 0–20% w/v, increments of 2%) and incubated for
15 hours at 37uC with aeration to determine the lowest
concentration of each antimicrobial compound that prevented
bacterial growth. Each experiment was repeated three times
independently.
Serum sensitivity
For analyses of serum sensitivity, 16107 bacteria from cultures
grown to stationary phase were washed three times in DPBS and
incubated in 10% human serum for one hour at 37uC with slight
agitation. The number of viable bacteria was quantified by
spreading serial 10-fold dilutions on LB agar plates containing the
appropriate antibiotics.
Animal experiments
For competitive infection experiments, groups (n = 4) of female
mice (C57BL/6J or 129/svJ Jackson Laboratory) aged 6 to 8
weeks were inoculated intragastrically with 20 mg streptomycin in
a volume of 0.2 ml 48 hours prior to intragastric inoculation with
either 0.1 ml sterile LB broth or 16107 CFU of the indicated
mixtures of S. Typhimurium strains. Alternatively, animals were
inoculated intragastrically with either 0.1 ml sterile LB broth or
16107 CFU of the indicated mixtures of S. Typhimurium strains
without being pretreated with streptomycin. Fecal pellets were
collected and organs were harvested at day 4 (C57BL/6J) or day 7
(129/svJ) after infection. Fecal and tissue samples were homoge-
nized in PBS, serially diluted and plated on selective media to
enumerate CFU. The competitive index (CI) was calculated by
dividing the ratio of wild-type to mutant bacteria in homogenates
(output) by the ration present in the inoculum (input). In some
experiments, 129/SvJ mice were fed a normal rodent diet (Harlan-
Teklad) supplemented with the bile acid sequestrant cholestyr-
amine resin (2%, The Dow Chemical Company) starting the day
before streptomycin treatment and continuing throughout the
experiment.
For metabolite profiling, groups of 4 mice (C57BL/6J) received
20 mg streptomycin in a 0.1 ml volume intragastrically and were
inoculated intragastrically 24 hours later with either 0.1 ml sterile
LB broth or 16109 CFU of S. Typhimurium in LB broth. The
cecum was collected four days after infection, contents were
removed and metabolites from the mucosal surface were extracted
by five washes with 0.2 ml sterile UltraPure distilled water (Gibco).
Table 3. Oligonucleotide primers used in this study.
Designation Purpose Sequence (59 to 39)a
50 pGP704 sequencing primer used to confirm insertion mutants GCATTTATCAGGGTTATTGTCTC
52 Amplification of fepE for complementation TCCCTGCAGCAGGTCATACGGCATGCCATC
53 GGAGAATTCTCAGACTAACCGTTCATCTATC
62 Amplification of fepE for insertional inactivation ATCGCGCCCGGGGGGTTGCTTCTGTCCTTTCTGC
63 TTCAGGGTCGACTTTTACCGCCTGACCATTGC
130 Confirmation of fepE insertion TGCTACCGTTTTCGCCTTTG
131 ACATTCATTGCCGCCAGTTG
150 Amplification of wzzB for insertional inactivation ATCATACCGCGGACAGTTATGGCGTGGGAAGATG
151 CGTCTACTCGAGCGGAGAAAAGACCAGTGGACG
160 Confirmation of wzzB insertion GCTTCATCCTTTTTTTAGTTAGG
161 TTACAAGGCTTTTGGCTTATAGC
170 TTCACCGTCGACGCGAATGGCCTCAATCCG
171 TTTACCTCTAGACAGAGATTCTAACAGCAAGTCAG
172 TTCACCTCTAGATTTACCCGAAAAGCCGGATAGC
173 TTCACGGTCGACCGCATCAGCCGTTATTTACCC
174 TTCACCGTCGACACGGGCGTTGTTTCTGCCTT
175 TTTACCCCCGGGCCCACACTGATGACAAAGC
263 Amplification of pmrE for insertional inactivation TCTAGACCCGCAGCAGTGATG
264 CCCGGGAAAATAAGCGACTCG
aRestriction endonuclease cleavage sites are underlined.
doi:10.1371/journal.ppat.1002918.t003
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Debris was removed by centrifugation at 20,0006g for 5 minutes,
the supernatant was filter sterilized to remove bacteria and
submitted to metabolite profiling analysis.
Ethics statement
All animal experiments were performed according to Associa-
tion for Assessment and Accreditation of Laboratory Animal Care
(AAALAC) guidelines. All animal experiments were approved by
the Institutional Animal Care and Use Committee at the
University of California, Davis.
Histopathology
Cecal tissues were formalin fixed, sectioned, stained with
hematoxylin and eosin (H&E), and submitted to a veterinary
pathologist for blinded scoring using a scale described previously
[8]. Representative images of tissue sections were taken using an
Olympus BX41 microscope.
Metabolite profiling
Reagents and standards: Liquid chromatography/mass spec-
trometry (LC/MS) grade acetonitrile and acetone (Burdick and
Jackson, VWR International, West Chester, PA, USA) and extra
pure ammonium formate (EMD, Gibbstown, NJ, USA) were
purchased. Ultrapure water was supplied by an in house Millipore
system (Billerica, MA, USA). Each lot of organic solvents was
investigated by LC/MS infusion. Utilizing ultrapure water,
aqueous buffer for liquid chromatography/electrospray ionization
mass spectrometry (LC/ESI-MS) and a stock solution (1 mg/ml)
of tuning reference compound was prepared freshly on a daily
basis in a solvent system identical to the initial mobile phase
composition of LC.
Hydrophilic interaction chromatography (HILIC)-LC/ESI-MS
profiling: HILIC-LC/ESI-MS analysis [39] was performed with
the use of a modified silica-based column (Luna HILIC Diol,
150_3 mm, 3 mm particle size; Phenomenex, Torrance, CA,
USA). The mobile phases were 100 mM ammonium formate
(pH 4.0) (A) and acetonitrile (B) (flow rate 0.4 mL/min at 40uC).
After a 2 minute isocratic run at 3% A, a sequential ramping
scheme was followed up to 40% A for total injection time of
20 min. The injection volume was set to 10 ml. The entire effluent
from the high-pressure liquid chromatography (HPLC) column
was directed into the ESI source of a linear trap quadrupole (LTQ)
linear ion trap (LIT) mass spectrometer (Thermo Fisher, San Jose,
CA, USA) operated under Xcalibur software (v1.4, Thermo
Fisher). The electrospray voltage was set to 5 kV. Nitrogen sheath
and auxiliary gas flow were set at 60 and 20 arbitrary units,
respectively. The ion transfer capillary temperature was set at
350uC with typical ion gauge pressure of 0.9061025. Full scan
spectra were acquired from 100–1500 amu at unit mass resolution
with maximum injection time set to 200 ms in one micro scan.
Acquisition was performed in both positive/negative switching
modes. A sucrose tune file in negative/positive modes at high LC
flow rate was used during all the LC/ESI-MS acquisitions on the
LTQ mass spectrometer.
Metabolite annotation: Annotation of the MS and MS/MS
spectra was done using commercial NIST05/Wiley Registry;
METLIN, Mass-Bank, Human Metabolome Database, Lipid
Maps, and in-house built mass spectral libraries. Annotation was
further validated with de novo structure identification. The unique
elemental formula was searched against the CAS database using
the strategy of Explore Substances – Chemical Structure
(American Chemical Society, Washington, DC) for known
compounds, or input into the MolGen 3.5,20 generating all of
the possible structural isomers corresponding to the elemental
formula. The chemical structures were saved and imported to
Mass Frontier 5.0 (HighChem Ltd., Bratislava, Slovakia) for MS/
MS fragmentation modeling analysis. The Mass Frontier Frag-
ments and Mechanisms module is an expert system providing
information about basic fragmentation and rearrangement pro-
cesses based on literature, starting from a user-supplied chemical
structure. The theoretical fragments generated by Mass Frontier
were compared to those acquired from LC/MS. Parent
compounds that had the best match of MS/MS fragmentation
pattern were considered as the molecular structures of the
potential biomarkers. For validation purpose, the proposed
molecules were searched against chemical structure and property
databases or search engines such as publicly available PubChem,
Chemical Structure Lookup Service (CSLS), CRC Dictionary of
Natural Products (DNP), ChemSpider, and proprietary Beilstein
Database using MDL Crossfire Commander and Chemical
Abstracts Database (CAS) using SciFinder Scholar.
Raw data processing: Prior to data processing, original Xcalibur
LC/MS files were converted into netCDF format using the
XConverter (Thermo Fisher), then converted into WIFF format
usingAnalyst QS for use in MarkerView software (v1.2, Applied
Biosystems, Foster City, CA, USA). For HILIC LC/MS data,
peak finding options were set as follows: subtraction offset, 10
scans; subtraction multiplication factor, 1.3; noise threshold, 3;
minimum spectral peak width, 5 amu; minimum retention time
peak width, 5 scans; and maximum retention time width, 1000
scans. Peak alignment options were set as follows: retention time
tolerance, 0.5 min; mass tolerance, 0.8 amu; and maximum
number of peaks, 5000. Peaks found in fewer than 3 of the samples
were discarded using filter setting. Peak area integration was
performed using raw data. Datasets were normalized using
Euclidean norm by scaling each sample-vector to unit vector
norm, which can be interpreted geometrically as a projection of
the samples x to a hyper-sphere with the length of this sample
vector scaled to one. Peaks were, then, normalized to the total
absolute area of all detected metabolites in each sample. Datasets
were routinely processed in MarkerView for principal component
analysis. The data that constituted retention time, mass-to-charge
ratio, and peak areas of detected and aligned peaks were exported
from MarkerView into into MetaboAnalyst and MetPA for further
analysis.
Quantitative determination of total bile acids
Colon contents were weight, homogenized in 1 ml PBS and
analyzed using a colorimetric Total Bile Acids Assay Kit (Bio-
Quant). Briefly, conversion of bile acids and Thio-NADH to 3-
keto steroids and Thio-NADH by 3-a.hydroxysteroid dehydroge-
nase was followed by measuring change of absorbance at 405 nm.
Bile acid concentrations were determined using a conjugated
cholic acids standard using a protocol provided by the manufac-
turer.
Statistical analysis
Competitive indices were converted logarithmically (log10) prior
to statistical analysis using a one-tailed parametric test (Student’s t
tests). Concentrations of total bile acids were analyzed using a one-
tailed Student’s t tests. A P value of ,0.05 was considered to be
significant.
Fold differences in metabolites between mock-infected mice and
S. Typhimurium infected mice were converted logarithmically
(log2) and a Student’s t was used to determine whether differences
were statistically significant. False discovery rates were estimated
using the q value method. A P value of ,0.05 and q value of ,0.1
were considered a significant change.
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Supporting Information
Figure S1 Very long O-antigen chains are not required for
serum resistance. (A) Silver stained SDS-PAGE of LPS prepara-
tions from the indicated S. Typhimurium strains. Plasmid pRC37
carries the cloned fepE gene. Positions of short, long and very long
O-antigen chains (arrows) are indicated on the right. (B) Recovery
of the indicated S. Typhimurium strains after one-hour incubation
in 10% human serum. ns, not significantly different.
(PDF)
Figure S2 Very long O-antigen chains confer a fitness
advantage in the C57BL/6 mouse colitis model. (A and B)
C57BL/6J mice were pre-treated with streptomycin and infected
with an equal mixture of the S. Typhimurium wild type and a fepE
mutant. (A) Competitive indices recovered from feces and colon
contents. (B) Competitive indices recovered from the liver and
spleen. Bars represent geometric means 6 standard error.
(PDF)
Figure S3 Very long O-antigen chains are expressed in vivo.
Detection of very long O-antigen (VL Oag) by Western blot in
samples from mice used in the experiment depicted in Figure 1.
Mice (129/SvJ) were treated with streptomycin (strep+) or were
left untreated (strep2) and were subsequently infected with sterile
medium (LB control, lanes 7 and 8)) or with an equal mixture of
the S. Typhimurium wild type and a fepE mutant (WT/fepE, lanes
3–6). Samples from in vitro grown S. Typhimurium wild type (lane
1) and a fepEmutant (lane 2) were loaded as a control. The amount
of LPS loaded in each lane was normalized based on CFU counts
for S. Typhimurium. NA, not applicable.
(PDF)
Figure S4 Very long O-antigen chains confer a fitness
advantage in the CBA/J mouse colitis model. (A and B) CBA/J
mice were pre-treated with streptomycin and infected with an
equal mixture of the S. Typhimurium wild type (wt) and a fepE
mutant (competitive infection design). (A) Competitive indices (CI)
recovered from feces and colon contents. (B) Competitive indices
recovered from the liver and spleen. (C) CBA/J mice were pre-
treated with streptomycin and infected with an equal mixture of a
S. Typhimurium fepE mutant (RC61) and a derivative of RC61
carrying an intact copy of the fepE gene inserted chromosomally
(RC62). Competitive indices recovered from feces, colon contents,
liver or spleen at the indicated time points are shown. (D and E)
Mice (CBA/J) were pre-treated with streptomycin and infected
with either the S. Typhimurium wild type (open bars) or a fepA
mutant (closed bars) (single infection design). (D) CFU recovered
from the liver and spleen. (E) CFU recovered from colon contents
or from feces over time. Bars represent geometric means 6
standard error. **, P,0.01, ns, not significantly different.
(PDF)
Figure S5 Principle component analysis score plot of HILIC-
LC/ESI-MS data. Principle component analysis of data consti-
tuting retention time, mass-to-charge ratio, and peak areas of
detected and aligned peaks was performed for samples from four
mock-infected mice (63_1, 63_2, 63_3 and 63_4) and four S.
Typhimurium-infected mice (64_1, 64_2, 64_3 and 64_4). Dashed
lines in the principle component analysis plot illustrate that
samples from S. Typhimurium-infected mice (green crosses) were
well separated from mock-infected controls (red triangles).
(PDF)
Figure S6 Very long O antigen chains confer a fitness advantage
at concentrations of bile acids that are below the MIC of a fepE
mutant. The S. Typhimurium wild type (IR715) or a fepA mutant
(RC31) were grown in LB broth containing 3% (A), 0.3% (B),
0.03% (C) or 0.003% sodium choleate (D) and growth was
followed by measuring the optical density at a wavelength of
600 nm (OD600).
(PDF)
Table S1 Compounds identified by metabolite profiling. m/
z_Rt (min), mass to charge ratio (m/z) and retention time (Rt) in
minutes.
(PDF)
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